Filed: 11/8/2024ACC: 0000950123-24-010733
📋 What this filing means
VERSANT VENTURE MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 6 equity positions with a total reported market value of $63.57M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
6
Positions
$63.57M
Total AUM (reported)
10.14M
Total Shares
Allocation by class
COMMON STOCK$40.15M63.2%
COMMON SHARES$23.42M36.8%
Portfolio Concentration
Top 3$50.10M78.8%
4–10$13.47M21.2%
Top 3 weight
78.8%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 10.14M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
10.14M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other6
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings6
Rows:
CRISPR Therapeutics AG
OTRShares498.56K
TypeSH
Market value$23.42M
36.84%
Sole
0.00
Shared
498.56K
None
0.00
Contineum Therapeutics, Inc.
OTRShares918.16K
TypeSH
Market value$17.57M
27.64%
Sole
0.00
Shared
918.16K
None
0.00
Repare Therapeutics, Inc.
OTRShares2.65M
TypeSH
Market value$9.10M
14.32%
Sole
0.00
Shared
2.65M
None
0.00
Skye Bioscience, Inc.
OTRShares2.01M
TypeSH
Market value$7.85M
12.35%
Sole
0.00
Shared
2.01M
None
0.00
Adverum Biotechnologies, Inc.
OTRShares506.82K
TypeSH
Market value$3.56M
5.60%
Sole
0.00
Shared
506.82K
None
0.00
Gritstone Oncology, Inc.
OTRShares3.56M
TypeSH
Market value$2.07M
3.25%
Sole
0.00
Shared
3.56M
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CRISPR Therapeutics AGOTR | Common Shares | 498.56K | SH | $23.42M 36.84% | 0.00 | 498.56K | 0.00 |
Contineum Therapeutics, Inc.OTR | Common Stock | 918.16K | SH | $17.57M 27.64% | 0.00 | 918.16K | 0.00 |
Repare Therapeutics, Inc.OTR | Common Stock | 2.65M | SH | $9.10M 14.32% | 0.00 | 2.65M | 0.00 |
Skye Bioscience, Inc.OTR | Common Stock | 2.01M | SH | $7.85M 12.35% | 0.00 | 2.01M | 0.00 |
Adverum Biotechnologies, Inc.OTR | Common Stock | 506.82K | SH | $3.56M 5.60% | 0.00 | 506.82K | 0.00 |
Gritstone Oncology, Inc.OTR | Common Stock | 3.56M | SH | $2.07M 3.25% | 0.00 | 3.56M | 0.00 |